Valiant Organics Limited has informed the Exchange about Investor Presentation
September 26, 2025
To, Listing/Compliance Department BSE LTD Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400 001
To, Listing/Compliance Department National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai- 400 051.
SCRIP CODE – 540145
SYMBOL- VALIANTORG
Dear Sir / Madam,
Sub: Presentation to the Shareholders.
Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
Please find attached herewith presentation made to the shareholders of the Company at the 20th Annual General Meeting held today i.e. September 26, 2025 for your records.
Please take note of the above on your record.
Thanking You.
Yours faithfully,
For Valiant Organics Limited
Kaustubh Kulkarni Company Secretary ICSI M.NO: A52980
Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund West, Mumbai 400080, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348
A n n u a l G e n e r a l M e e t i n g F Y 2 0 2 4 – 2 5 | S e p t e m b e r 2 0 2 5
1
SNAPSHOT
One of the largest chlorophenol derivatives manufacturer globally
One of the leading manufacturer of Benzene derivatives products
One of the largest domestic PNA manufacturer
One of the few commercial players in Ortho Anisidine and Para Anisidine
Amongst 1st few domestic PAP Manufacturers
Diversified client base across Pharmaceuticals, Dyes & Pigments, Agrochemicals and specialty chemicals.
6 Manufacturing units across 5 Locations
5 Zero Liquid Discharge plants
Total Production Capacity of 70,000 TPA
900+ Employees
2
COMPANY OVERVIEW
3
Company Overview
Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India.
The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmaceuticals, dyes, pigments, and veterinary medications.
Key chemistries include Chlorination, Hydrogenation, Ammonolysis, Acetylation, Sulphonation, Methoxylation amongst others.
Over the years the company has primarily focused on manufacturing specialty chemicals that have a high demand but low supply and are primarily dependent on imports.
The company is listed on both the BSE and NSE with a market capitalization of INR ~ 730 Cr. as on 31st March 2025.
Operating Revenue (INR Cr) and EBITDA Margin (%)
FY25 Revenue Break-up – Chemistries
FY25 Revenue Break-up – End user Industry
1,153
1,052
[VALUE]
[VALUE]
1400
1200
1000
800
600
400
200
0
723
719
5.28%
7.47%
50.00%
45.00%
40.00%
35.00%
30.00%
25.00%
20.00%
15.00%
10.00%
5.00%
0.00%
FY22
FY23 Revenue
FY24
EBITDA Margin
FY25
Others, 5%
Ammonolysis, 28%
Chlorination, 20%
Dyes & Pigments, 52%
Hydrogenation , 47%
Pharmaceutica ls, 13%
Specialty Chemicals, 10%
Agro Chemicals, 25%
*Pursuant to the allotment of further equity shares through IPO by the Company's material step down subsidiary namely, Valiant Laboratories Limited ("VLL"), the stake of Company's subsidiary Dhanvallabh Ventures LLP in VLL has been diluted to 46.83% and accordingly VLL has ceased to be a step-down subsidiary of the Company and has become an associate company w.e.f. October 04,2023. Hence, consolidated financial of previous periods and YTD results are not comparable.
Valiant Organics Limited | AGM FY24-25
4
Manufacturing Footprint
CHLORINATION – SARIGAM Capacity: 18,000 MTPA • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • 2,4,6 TCP
AMMONOLYSIS - VAPI • •
Capacity: 10,000 MTPA Products: PNA, OCPNA
AMMONOLYSIS - TARAPUR Capacity: 6,600 MTPA • Products: PNA •
HYDROGENATION & METHOXYLATION- JHAGADIA UNIT 1 • •
Capacity: 28,800 MTPA Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS
HYDROGENATION – JHAGADIA UNIT 2 • •
Capacity: 12,000 MTPA Products: PAP, PHARMA INTERMEDIATES
ACETYLATION & SULPHONATION – AHMEDABAD • •
Capacity: 1,800 MTPA Products: 6 ACETYL OAPSA, OA/PA ACETANILIDE, OT5SA
Valiant Organics Limited | AGM FY24-25
5
Chemistries And Product Basket
Ammonolysis
Key Products: • •
Para Nitro Aniline Ortho Chloro Para Nitro Aniline
Industries Served: • •
Dyes Pigments
FY25 Revenue Share
47%
6
28%
Hydrogenation
Ortho Anisidine Para Anisidine IPPCA
Key Products: • • • • Meta Chloro Aniline Para Amino Phenol • Ortho Amino Phenol •
Industries Served: • • • •
Dyes Pigments Pharmaceutical Agro Chemicals
Others Acetylation Key Products: • • •
6 Acetyl OAPSA OA Acetanilide PA Acetanilide
Industries Served: • Dyes
Sulphonation Key Products: OT5SA • 4B Acid • 2B Acid •
Methoxylation Key Products: • •
Ortho Nitro Anisole Para Nitro Anisole
Industries Served: • Dyes • Pigments
Industries Served: • Dyes • Pigments
20%
Chlorination
5%
Key Products: • • • • •
Para ChloroPhenol (PCP) Ortho ChloroPhenol (OCP) 2,4 Di Chlorophenol (2,4 DCP) 2,6 Di ChloroPhenol (2,6 DCP) 2,4,6 Tri ChloroPhenol (2,4,6 TCP)
Industries Served: Agro Chemicals • Cosmetics • Veterinary • Pharmaceuticals •
Valiant Organics Limited | AGM FY24-25
6
Key Strengths
Domain expertise and broad process understanding in a variety of chemistries. The executive team is made up of first-generation technocrats with more than 50 years of collective expertise.
Wide supply chain provides the continuous availability of adequate and high-quality raw materials and manufacturing.
Plant locations are strategically located near ports to provide a competitive advantage, significant logistical cost savings, and faster delivery times.
Robust Business Model
Integrated Operations
Strong Customer Relations
Distinct Product Portfolio
Domain Knowledge
Widespread Supply Chain
Strategic Location of Plants
Diverse product range and client base across numerous industries and countries provides a sustainable business model in multiple chemistries by lowering product, industry, and geographical risk.
Multi-use and backward integrated plants to produce a wide range of products and tailor them to meet the diverse needs, technical qualifications, batch sizes, and delivery schedules of our clients.
Established multi-year relationships with clients in both domestic and international markets due to high-quality standards, innovative production capabilities.
Manufacturing a diverse range of intermediates as well as value-added products for a variety of industries.
Valiant Organics Limited | AGM FY24-25
7
FINANCIAL OVERVIEW
8
Consolidated Financial Highlights
Operational Revenue (INR Cr)
EBITDA (INR Cr) & EBITDA Margins (%)
PAT (INR Cr) & PAT Margins (%)
1,153
1,052
1,400
1,200
1,000
800
600
400
200
-
723
719
205
164
17.77%
15.62%
38 5.28%
54
7.47%
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
Net Debt to Equity (x)
0.64
Net Worth (INR Cr)
0.32
0.32
0.33
522
585
583
570
900
800
700
600
500
400
300
200
100
-
FY22
FY23
FY24
FY25
FY22
FY23
FY24
FY25
300
0
-300
30.00%
25.00%
20.00%
15.00%
10.00%
5.00%
0.00%
-5.00%
11.09%
128
9.75%
103
FY22
FY23
FY24
-8
FY25
-3
-1.16%
-0.47%
Return on Capital Employed & Return on Equity (%)
26.31%
22.10%
ROCE
ROE (%)
17.56%
14.77%
1.26%
2.72%
FY22
FY23
-1.14%
FY24
-0.47%
FY25
Valiant Organics Limited | AGM FY24-25
9
THANK YOU
11